Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Lung Diseases: Current Status and Perspectives
Soraia C. Abreu, Miquéias Lopes‐Pacheco, Daniel J. Weiss, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

The Role of MSC in Wound Healing, Scarring and Regeneration
Raquel Guillamat‐Prats
Cells (2021) Vol. 10, Iss. 7, pp. 1729-1729
Open Access | Times Cited: 265
Endothelial cell dynamics in sepsis-induced acute lung injury and acute respiratory distress syndrome: pathogenesis and therapeutic implications
Xinyu Qiao, Junhao Yin, Zhihuan Zheng, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 27
The MSC-EV-microRNAome: A Perspective on Therapeutic Mechanisms of Action in Sepsis and ARDS
Claúdia C. dos Santos, Miquéias Lopes‐Pacheco, Karen English, et al.
Cells (2024) Vol. 13, Iss. 2, pp. 122-122
Open Access | Times Cited: 21
Mouse mesenchymal stem cell-derived exosomal miR-466f-3p reverses EMT process through inhibiting AKT/GSK3β pathway via c-MET in radiation-induced lung injury
Yi Li, Zhufu Shen, Xiao Jiang, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 50
Stem cell-based therapy for pulmonary fibrosis
Wenzhao Cheng, Yiming Zeng, Dachun Wang
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 39
Safety and efficacy study of allogeneic human menstrual blood stromal cells secretome to treat severe COVID-19 patients: clinical trial phase I & II
Mina Fathi-Kazerooni, Samrand Fattah-Ghazi, Maryam Darzi, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 38
Liposomes or Extracellular Vesicles: A Comprehensive Comparison of Both Lipid Bilayer Vesicles for Pulmonary Drug Delivery
Ali Al-Jipouri, Samah Hamed Almurisi, Khater AL-Japairai, et al.
Polymers (2023) Vol. 15, Iss. 2, pp. 318-318
Open Access | Times Cited: 31
Emerging delivery approaches for targeted pulmonary fibrosis treatment
Rimpy Diwan, Himanshu Bhatt, Elfa Beaven, et al.
Advanced Drug Delivery Reviews (2023) Vol. 204, pp. 115147-115147
Open Access | Times Cited: 27
Mesenchymal stromal cells facilitate resolution of pulmonary fibrosis by miR-29c and miR-129 intercellular transfer
Nataliya Basalova, Arbatskiy Mikhail, Попов Владимир, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 7, pp. 1399-1412
Open Access | Times Cited: 24
The role of epithelial cells in fibrosis: Mechanisms and treatment
Liuyi Luo, Wei Zhang, Siyao You, et al.
Pharmacological Research (2024) Vol. 202, pp. 107144-107144
Open Access | Times Cited: 9
Highlights on Future Treatments of IPF: Clues and Pitfalls
Alessandro Libra, Enrico Sciacca, Giuseppe Muscato, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8392-8392
Open Access | Times Cited: 8
Mesenchymal Stem Cell-Derived Exosomes Exhibit Promising Potential for Treating SARS-CoV-2-Infected Patients
Alok Raghav, Zeeshan Ahmad Khan, Viabhav Kumar Upadhayay, et al.
Cells (2021) Vol. 10, Iss. 3, pp. 587-587
Open Access | Times Cited: 42
Proteomics profile of mesenchymal stromal cells and extracellular vesicles in normoxic and hypoxic conditions
Cássia L. Braga, Luana Rocha da Silva, Renata Trabach Santos, et al.
Cytotherapy (2022) Vol. 24, Iss. 12, pp. 1211-1224
Closed Access | Times Cited: 29
Progress in understanding and treating idiopathic pulmonary fibrosis: recent insights and emerging therapies
Hehua Guo, Jiazheng Sun, Siyu Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 21
Mesenchymal stem cells-derived exosomes carrying microRNA-30b confer protection against pulmonary fibrosis by downregulating Runx1 via Spred2
Liang Zhu, Yun Xu, Jianqing Wang, et al.
Molecular Genetics and Genomics (2024) Vol. 299, Iss. 1
Closed Access | Times Cited: 6
Therapeutic role of mesenchymal stem cell-derived exosomes in respiratory disease
Mehdi Jahedi Zargar, Saeid Kaviani, Mohammad Vasei, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 27
Extracellular Lipids in the Lung and Their Role in Pulmonary Fibrosis
Olivier Burgy, Sabrina Loriod, Guillaume Beltramo, et al.
Cells (2022) Vol. 11, Iss. 7, pp. 1209-1209
Open Access | Times Cited: 26
Eugenol-Preconditioned Mesenchymal Stem Cell-Derived Extracellular Vesicles Promote Antioxidant Capacity of Tendon Stem Cells In Vitro and In Vivo
Xiangze Li, Zhan Su, Kaiying Shen, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-20
Open Access | Times Cited: 23
Laboratory Tools to Predict CFTR Modulator Therapy Effectiveness and to Monitor Disease Severity in Cystic Fibrosis
Mafalda Bacalhau, Mariana Camargo, Miquéias Lopes‐Pacheco
Journal of Personalized Medicine (2024) Vol. 14, Iss. 1, pp. 93-93
Open Access | Times Cited: 5
Precision Nanomedicine with Bio-Inspired Nanosystems: Recent Trends and Challenges in Mesenchymal Stem Cells Membrane-Coated Bioengineered Nanocarriers in Targeted Nanotherapeutics
Mirza Salman Baig, Anas Ahmad, Rijawan Rajjak Pathan, et al.
Journal of Xenobiotics (2024) Vol. 14, Iss. 3, pp. 827-872
Open Access | Times Cited: 5
Mesenchymal stem cell-based therapy as a new therapeutic approach for acute inflammation
Kamal Abdolmohammadi, Tayebeh Mahmoudi, Mina Alimohammadi, et al.
Life Sciences (2022) Vol. 312, pp. 121206-121206
Closed Access | Times Cited: 20
Functional enhancement strategies to potentiate the therapeutic properties of mesenchymal stromal cells for respiratory diseases
Miquéias Lopes‐Pacheco, Patrícia R. M. Rocco
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12
Regenerative and translational medicine in COPD: hype and hope
Lucas Pires Guarnier, Lincoln Gozzi Moro, Francislaine Aparecida dos Reis Lívero, et al.
European Respiratory Review (2023) Vol. 32, Iss. 169, pp. 220223-220223
Open Access | Times Cited: 12
Mesenchymal stem cells and their derived exosomes for ALI/ARDS: A promising therapy
Dan Liang, Chang Liu, Mei Yang
Heliyon (2023) Vol. 9, Iss. 10, pp. e20387-e20387
Open Access | Times Cited: 11
Acute respiratory distress vs healthy lung environments differently affect mesenchymal stromal cell extracellular vesicle miRNAs
Sara Rolandsson Enes, Irakli Dzneladze, Thomas H. Hampton, et al.
Cytotherapy (2025)
Closed Access
Page 1 - Next Page

Scroll to top